Director Site Engagement & Monitoring Excellence
Eikon Therapeutics
Director Site Engagement & Monitoring Excellence
Eikon Therapeutics
Develops therapies with single-molecule tracking
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.
Position
The Director Study Site Engagement & Monitoring Excellence (CONTRACT) will be responsible for leading the development and execution of Eikon’s global trial site engagement strategy, including oversight and accountability for all internal/external managed site monitoring activities to ensure predictable delivery of high-quality data and establish Eikon as a preferred sponsor for clinical sites.
The Director will ensure effective collaboration with clinical study teams, and Functional Service Provider (FSP) partners, to implement excellent site relationship management and site monitoring activities to accelerate operational excellent delivery of Eikon’s clinical programs.
This role will require a minimum of 3 days a week of onsite presence (or more as business needs require) in either of our California or New Jersey offices to ensure effective management, operational excellence and high-performance delivery of clinical studies and to support the expected significant team growth & collaboration.
What You’ll Do
Strategic Leadership
Operational Support
Cross Functional Collaboration
Qualifications
The expected hourly range for this role is $100.50 to $121.00 depending on skills, competency, and the market demand for your expertise.
Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.
We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.
Develops therapies with single-molecule tracking
Eikon Therapeutics develops medicines by studying living cells with advanced engineering and data science. Its SMT platform visualizes protein motion in real time, while AI and automated workflows analyze these movements to map molecular interactions and identify drug targets. The company blends data science, chemistry, biology, engineering, and clinical expertise to inventory dynamic cellular processes at high scale, rather than relying on static snapshots. Its goal is to create therapies that improve and extend patients’ lives by targeting dynamic protein interactions inside cells.
Explore more opportunities at Eikon Therapeutics